Accenture Rises on AI Partnership with Anthropic; Novo Nordisk Falls Amid Investor Disappointment
Accenture shares rose nearly 4% after announcing a partnership with artificial intelligence firm Anthropic to test the safety of its advanced models. The collaboration involves embedding Accenture evaluators within Anthropic's operations, signaling progress in responsible AI development. In contrast, Novo Nordisk saw its stock fall as investors reacted negatively to what they viewed as insufficient concrete plans for a turnaround following Eli Lilly’s market gains with GLP-1 weight loss drugs. While the company pledged more than five blockbuster drug launches and over $23 billion in new sales, it failed to satisfy investor expectations. Arhaus shares also climbed nearly 9% after Jefferies upgraded its rating from hold to buy, citing improved brand awareness strategies and digital traffic growth.
Topics: Accenture partnership Arhaus upgrade Novo Nordisk performance